Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07016971 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment openedv7 Show 4 more changesShow less
    • Primary completion date: Apr 1, 2029 to Apr 3, 2029
    • Study completion date: Jul 1, 2029 to Jul 3, 2029
    • Start date changed from estimate of Apr 1, 2026 to Apr 3, 2026
    • Site details revised
  2. Secondary endpoints: details revised at 5 of 7 entriesv6
  3. Start date: Feb 1, 2026 to Apr 1, 2026v5 Show 4 more changesShow less
    • Primary completion date: Feb 1, 2029 to Apr 1, 2029
    • Study completion date: May 1, 2029 to Jul 1, 2029
    • Eligibility criteria expanded, about 212 words
    • Secondary endpoints: 6 to 7
  4. Re-verified, no change to tracked fieldsv4
  5. Primary completion date: Jan 31, 2028 to Feb 1, 2029
    • Start date: Sep 1, 2025 to Feb 1, 2026
    • Study completion date: Feb 28, 2028 to May 1, 2029
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if a commercially available cannabigerol (CBG)/cannabidiol (CBD) oil is safe, feasible to use, and can help reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN) in adults who have completed platinum-based chemotherapy for gastrointestinal cancers. The main questions it aims to answer are: Is CBG/CBD oil safe and well-tolerated over a 12-week treatment period? Can participants with CIPN use CBG/CBD oil consistently as part of their care? Does CBG/CBD oil help reduce pain, numbness, or other symptoms of CIPN? Participants will: Take CBG/CBD oil under the tongue (sublingually) twice daily for 12 weeks Complete regular symptom assessments and functional tests during study visits Provide blood samples for cannabinoid and metabolite level testing
Trial Details
NCT Number NCT07016971
Lead Sponsor Milton S. Hershey Medical Center
Conditions
(from sponsor)		 Chemotherapy-Induced Peripheral Neuropathy
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov